Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker
Purpose: The aim of this study was to determine the suitability of serum prolyl hydroxylase-3 (PHD3) as a diagnostic or monitoring biomarker of renal cell carcinoma (RCC). Materials and Methods: Between October 2013 and March 2015, we prospectively recruited study participants. The RCC group consist...
Main Authors: | Kwang Hyun Kim, Hyung Ho Lee, Young Eun Yoon, Joon Chae Na, Kyung Sup Kim, Woong Kyu Han |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Urological Association
2019-11-01
|
Series: | Investigative and Clinical Urology |
Subjects: | |
Online Access: | https://www.icurology.org/Synapse/Data/PDFData/2020ICU/icu-60-425.pdf |
Similar Items
-
Preoperative Renal Artery Embolization Before Radical Nephrectomy for Nonmetastatic Renal Cell Carcinoma: A Propensity Score Matched Analysis
by: Jin Noh, et al.
Published: (2023-11-01) -
Laparoscopic Radical Nephrectomy in the Current Era: Technical Difficulties, Troubleshoots, a Guide to the Apprentice, and the Current Learning Curve
by: Abhishek Pandey, et al.
Published: (2023-04-01) -
Comparison of Outcomes Between Radical Nephrectomy and Partial Nephrectomy in Clinical T2 Renal Cell Carcinoma: A Retrospective Korean Renal Cell Carcinoma Cohort Study
by: Younsoo Chung, et al.
Published: (2024-07-01) -
Small renal masses
by: Mandana Gholami, et al.
Published: (2023-01-01) -
Tumor enucleation for the treatment of T1 renal tumors: A systematic review and meta-analysis
by: Hyun Chul Chung, et al.
Published: (2022-03-01)